Mavrilimumab (CAM 3001) is a monoclonal antibody that binds to the alpha subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. GM-CSF might be a mediator of the hyperactive inflammatory response associated with respiratory failure and death[1].
Molecular Weight:
(143.168 kDa)
Purity:
98.37
CAS Number:
[1085337-57-0]
Target:
c-Fms
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
